1. Home
  2. DMAC vs PMM Comparison

DMAC vs PMM Comparison

Compare DMAC & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMAC
  • PMM
  • Stock Information
  • Founded
  • DMAC 2000
  • PMM 1989
  • Country
  • DMAC United States
  • PMM United States
  • Employees
  • DMAC N/A
  • PMM N/A
  • Industry
  • DMAC Biotechnology: Pharmaceutical Preparations
  • PMM Investment Managers
  • Sector
  • DMAC Health Care
  • PMM Finance
  • Exchange
  • DMAC Nasdaq
  • PMM Nasdaq
  • Market Cap
  • DMAC 274.1M
  • PMM 287.2M
  • IPO Year
  • DMAC N/A
  • PMM N/A
  • Fundamental
  • Price
  • DMAC $4.82
  • PMM $6.05
  • Analyst Decision
  • DMAC Strong Buy
  • PMM
  • Analyst Count
  • DMAC 3
  • PMM 0
  • Target Price
  • DMAC $7.00
  • PMM N/A
  • AVG Volume (30 Days)
  • DMAC 118.6K
  • PMM 118.3K
  • Earning Date
  • DMAC 11-13-2024
  • PMM 01-01-0001
  • Dividend Yield
  • DMAC N/A
  • PMM 4.68%
  • EPS Growth
  • DMAC N/A
  • PMM N/A
  • EPS
  • DMAC N/A
  • PMM 0.23
  • Revenue
  • DMAC N/A
  • PMM N/A
  • Revenue This Year
  • DMAC N/A
  • PMM N/A
  • Revenue Next Year
  • DMAC N/A
  • PMM N/A
  • P/E Ratio
  • DMAC N/A
  • PMM $26.52
  • Revenue Growth
  • DMAC N/A
  • PMM N/A
  • 52 Week Low
  • DMAC $2.14
  • PMM $5.00
  • 52 Week High
  • DMAC $6.41
  • PMM $6.42
  • Technical
  • Relative Strength Index (RSI)
  • DMAC 47.28
  • PMM 34.89
  • Support Level
  • DMAC $5.05
  • PMM $6.04
  • Resistance Level
  • DMAC $5.74
  • PMM $6.43
  • Average True Range (ATR)
  • DMAC 0.37
  • PMM 0.08
  • MACD
  • DMAC -0.08
  • PMM -0.03
  • Stochastic Oscillator
  • DMAC 28.10
  • PMM 16.10

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

Share on Social Networks: